NCT06343727 A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
| NCT ID | NCT06343727 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seven Oaks Hospital Chronic Disease Innovation Centre |
| Condition | Kidney Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-07-25 |
| Primary Completion | 2026-08-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2025-07-25 with a primary completion date of 2026-08-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare protein supplements in patients with kidney failure on dialysis. The main questions it aims to answer are: * To determine whether the supplementation of egg white protein pudding in a population of individuals with kidney failure on dialysis is feasible. * To determine whether egg white protein pudding supplementation improves serum albumin similar to other standard nutritional supplements. * To determine the effects of the egg white protein pudding on frailty measures, dietary intakes and analytes in the blood. Participants will receive either the egg white pudding (experimental) or control (Ensure plus) at the end of their dialysis treatments 3-days per week for 12 weeks.
Eligibility Criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the trial * Male or female aged ≥18 years with CKD * On chronic in-center hemodialysis for \> 3 months * Serum albumin \<35 g/L * No expected change in dialysis modality or relocation outside of Winnipeg during the intervention period (12 weeks) Exclusion Criteria: * Allergy to eggs * History of renal transplant * Serum albumin ≥ 35 g/L * Bowel diseases * Cancer * Pregnancy * Receiving chemotherapy treatment * Inability to consume treatment product * Allergy to study treatment ingredients * Planning on starting an exercise program during the duration of the trial * Inability to obtain written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06343727 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06343727 currently recruiting?
Yes, NCT06343727 is actively recruiting participants. Contact the research team at ntangri@sogh.mb.ca for enrollment information.
Where is the NCT06343727 trial being conducted?
This trial is being conducted at Winnipeg, Canada, Winnipeg, Canada.
Who is sponsoring the NCT06343727 clinical trial?
NCT06343727 is sponsored by Seven Oaks Hospital Chronic Disease Innovation Centre. The trial plans to enroll 54 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.